Coagulation and fibrinolytic profiles in patients with severe pulmonary hypertension.
暂无分享,去创建一个
R. Marlar | D. Badesch | C. Welsh | K. Hassell | D. Kressin
[1] W. Richter,et al. Hemostatic factors and the risk of myocardial infarction. , 1995, The New England journal of medicine.
[2] S. Thompson,et al. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. , 1995, The New England journal of medicine.
[3] O. Matsubara,et al. Plasma thrombomodulin in Wegener's granulomatosis as an indicator of vascular injuries. , 1994, Chest.
[4] B. Dahlbäck,et al. Resistance to activated protein C as a basis for venous thrombosis. , 1994, The New England journal of medicine.
[5] G. Pietra. Histopathology of primary pulmonary hypertension. , 1994, Chest.
[6] A. Lopes,et al. Abnormal multimeric and oligomeric composition is associated with enhanced endothelial expression of von Willebrand factor in pulmonary hypertension. , 1993, Chest.
[7] J. Mlczoch,et al. [Aminorex-induced, plexogenic pulmonary arteriopathy: 25 years later!]. , 1993, Zeitschrift fur Kardiologie.
[8] J. Moake,et al. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets. , 1993, Blood.
[9] P. Mulder,et al. Thrombotic lesions in primary plexogenic arteriopathy. Similar pathogenesis or complication? , 1993, Chest.
[10] B. Dahlbäck,et al. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[11] B. Binder,et al. Endogenous Fibrinolytic System in Chronic Large‐Vessel Thromboembolic Pulmonary Hypertension , 1992, Circulation.
[12] S. Rich,et al. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. , 1992, The New England journal of medicine.
[13] J. Griffin,et al. Direct detection of activated protein C in blood from human subjects. , 1992, Blood.
[14] A. J. Valente,et al. Pathogenesis of the atherosclerotic lesion , 1992 .
[15] E H Bergofsky,et al. Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry , 1991 .
[16] Levin Eg,et al. Thrombin and the thrombin-thrombomodulin complex interaction with plasminogen activator inhibitor type-1. , 1991 .
[17] F. Civantos,et al. A Comparative Study of Three Methods for the Visualization of von Willebrand Factor (vWF) Multimers , 1990, Thrombosis and Haemostasis.
[18] S. Kimura,et al. Plasma thrombomodulin in health and diseases. , 1990, Blood.
[19] A. Jaffe,et al. Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension. , 1990, Circulation.
[20] D. Green,et al. Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. , 1990, The Journal of clinical investigation.
[21] R. Marlar,et al. Protein C and protein S levels in two patients with acquired purpura fulminans , 1990, British journal of haematology.
[22] William,et al. Structure and function of thrombomodulin: a natural anticoagulant. , 1990, Blood.
[23] R. Virmani,et al. Heterogeneity of pathologic lesions in familial primary pulmonary hypertension. , 1988, The American review of respiratory disease.
[24] W. Williams,et al. Abnormal endothelial factor VIII associated with pulmonary hypertension and congenital heart defects. , 1987, Circulation.
[25] L. Hoyer,et al. von Willebrand factor abnormalities in primary pulmonary hypertension. , 1987, The American review of respiratory disease.
[26] V. Fuster,et al. Primary pulmonary hypertension: natural history and the importance of thrombosis. , 1984, Circulation.
[27] Z. Ruggeri,et al. von Willebrand's Disease. , 1983, Clinics in haematology.
[28] A. Ducoloné,et al. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. , 1981, Thorax.
[29] R. C. Franz,et al. A possible causal relationship between defective fibrinolysis and pulmonary hypertension. , 1979, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[30] D. S. Gordon,et al. Abnormal fibrinolysis in familial pulmonary hypertension. , 1973, The American journal of medicine.
[31] C. Wagenvoort,et al. Primary Pulmonary Hypertension: A Pathologic Study of the Lung Vessels in 156 Clinically Diagnosed Cases , 1970 .